Uncategorized

5 02, 2019

CanaQuest Medical Corp Announces Filing of Cannabis/Botanical Provisional Patents

2019-02-26T17:25:20+00:00February 5th, 2019|

UNIQUE BOTANICAL AND TETRAHYDROCANNABINOL (“THC’) FORMULATION TREATING PSYCHIATRIC DISORDERS WITHOUT THE NEGATIVE PSYCHIATRIC SIDE-EFFECTS OF THC TORONTO, Feb. 05, 2019 -- CANAQUEST MEDICAL CORP (fka ALGAE DYNAMICS CORP) (OTC: “ADYNF”) (the "Company" or “CanaQuest”), a company developing unique health products and nutraceuticals utilizing cannabis and botanical oil extracts, has filed two provisional patents which stem from its sponsored research program at Western University in London, Ontario, Canada. The provisional patents cover the United States and Canada. The provisional patents cover a unique formulation utilizing the cannabis cannabinoid, THC, and a botanical extract to treat various psychiatric disorders, with the unique feature of elimination of the negative side effects associated with THC such as euphoria. [...]

30 01, 2019

CanaQuest Medical Corp (formerly Algae Dynamics) and Jamaican Medical Cannabis Corporation Announce Preliminary Agreement on Global Production, Distribution

2019-02-26T17:25:15+00:00January 30th, 2019|

TORONTO, Jan. 30, 2019 -- CanaQuest Medical Corp. (OTC: “ADYNF”), a company focused on the development of unique health products and nutraceuticals utilizing cannabis and botanical oil extracts, and Jamaican Medical Cannabis Corporation (JMCC), a Toronto-headquartered company with rapidly expanding cannabis cultivation, processing and distribution operations in Jamaica, announced today that they have signed a preliminary agreement under which JMCC will exclusively provide Jamaican-based processing, packaging, warehousing and global distribution services for CanaQuests'’ new cannabinoid-rich mental health and nutraceutical products. The final agreement is anticipated to be completed and signed by March 31, 2019. As previously announced on August 2, 2018, the two companies completed a supply agreement under which JMCC will supply cannabis [...]

28 01, 2019

Algae Dynamics Corp Changing Name To CanaQuest Medical Corp

2019-02-23T21:32:39+00:00January 28th, 2019|

TORONTO, Jan. 28, 2019 -- ALGAE DYNAMICS CORP (OTC: "ADYNF") (the "Company"), a company focused on the development of unique health products and nutraceuticals utilizing cannabis and botanical oils, today announced it has changed its name to CanaQuest Medical Corp to better reflect its new strategic direction. CanaQuest is also seeking a new trading symbol, which it expects to announce in coming days. The strategic direction reflected in the name CanaQuest Medical Corp is the development, manufacture and worldwide distribution of formulations that combine the significant health benefits of Omega-3 essential fatty acids derived from algae oil and extracts of cannabis and botanical oils. The formulations that we have developed, and are continuing to [...]

29 10, 2018

ALGAE DYNAMICS CORP CLOSES SECOND TRANCHE OF CDN$947,000 UNIT OFFERING

2018-11-06T10:59:55+00:00October 29th, 2018|

TORONTO, October 19, 2018--ALGAE DYNAMICS CORP (OTC: “ADYNF”) (the "Company"), a company focused on the development of unique health products and nutraceuticals utilizing cannabis and botanical oil extracts, is pleased to announce that it has raised an additional CDN$527,000 pursuant to the closing of a second tranche of a private placement of units at a price of CDN$.40 per unit. This follows the company’s press release on August 3, 2018 when it announced funding of CDN$520,000 comprised of CDN$100,000 in convertible debentures and a further CDN$420,000 in units on the same terms, resulting in an aggregate of 2,367,792 units being issued and funding of approximately $1,047,000 in the aggregate. Each unit consists of one share [...]

3 08, 2018

ALGAE DYNAMICS CORP SECURES CDN$520,000 FUNDING FROM ACCREDITED INVESTORS

2018-10-16T23:19:27+00:00August 3rd, 2018|

TORONTO, Aug. 03, 2018 (GLOBE NEWSWIRE) -- ALGAE DYNAMICS CORP (OTC: “ADYNF”) (the "Company"), a company focused on the development of unique health products and nutraceuticals utilizing cannabis and botanical oil extracts, today announced it has received funding of CDN$520,000 through the sale of $100,000 Canadian 10% Convertible Debentures (convertible into 400,000 shares of common stock at $0.25 CAN) and $420,000 CAN through the sale of 1,050,000 shares of restricted Common stock at $0.40 CAN and the issuance of 525,000 purchase warrants at $0.75 CAN via an Offering Memorandum from accredited investors. The Company intends to use the funds to further support Dr. Steven Laviolette and his team at Western University and Dr. Jonathan Blay [...]

2 08, 2018

ALGAE DYNAMICS CORP SECURES BULK CANNABIS SUPPLY AGREEMENT FOR COLLABORATION PARTNERS

2018-10-16T23:19:32+00:00August 2nd, 2018|

TORONTO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- ALGAE DYNAMICS CORP (OTC: “ADYNF”) (the "Company"), a company focused on the development of unique health products and nutraceuticals utilizing cannabis and botanical oil extracts, has secured a supply agreement to enable Canadian Licensed Producers and International Licensed Importers access to bulk cannabis deliveries in anticipation of licensing agreements for our proprietary Cannabis formulated products. Recent Developments in our Collaboration with Western University The researchers at Western University, the Company’s scientific collaboration team, have developed a very unique formulation involving cannabis and other botanical extracts. Western University’s Dr. Laviolette said, “We are pleased to report significant progress on our ongoing projects with Algae Dynamics. We are continuing to [...]

6 03, 2018

ALGAE DYNAMICS CORP PROVIDES CORPORATE UPDATE

2018-10-16T23:19:39+00:00March 6th, 2018|

TORONTO, March 06, 2018 (GLOBE NEWSWIRE) -- ALGAE DYNAMICS CORP (OTC: “ADYNF”) (the "Company"), a company focused on the development of unique health products and nutraceuticals utilizing cannabis and algae oils, today provided a corporate update. The Company is focused on initiatives designed to build shareholder value. The key initiatives are as follows: Continued Research and Product Development into Nutraceutical Formulations utilizing cannabis and algae oils. Leveraging our previously announced C$400,000 research grant from MITACS, a not-for-profit, Canadian national research organization, Western University has made significant progress in its research into anxiety, depression, schizophrenia, and post-traumatic stress disorder, drawing on twelve years of cannabis compound research. Preparing Patent Filing. A key nutraceutical formulation for anxiety [...]

16 11, 2017

ALGAE DYNAMICS CORP ANNOUNCES C$400,000 RESEARCH GRANT FROM MITACS TO SUPPORT CANNABIS RESEARCH WITH UNIVERSITY OF WESTERN ONTARIO

2018-10-16T23:19:46+00:00November 16th, 2017|

TORONTO, Nov. 16, 2017 (GLOBE NEWSWIRE) -- ALGAE DYNAMICS CORP (OTC: ADYNF) (the "Company"), a company focused on the development of unique health products and pharmaceuticals utilizing cannabis and algae oils, today announced that it and the University of Western Ontario have been awarded C$400,000 in project funding from Mitacs, a Canadian not-for-profit organization committed to supporting research-based innovation. The funds will be used to support the previously announced research agreement by the Company and University of Western Ontario to investigate the role of cannabis-derived phytocannabinoid formulations for the development of novel mental health pharmacotherapies. This project support will run for 3 years at the University of Western Ontario, headed by Dr’s. Steven Laviolette and [...]

15 11, 2017

ALGAE DYNAMICS CORP SECURES US $250,000 INVESTMENT FROM TEEWINOT LIFE SCIENCES CORPORATION

2018-10-16T23:20:17+00:00November 15th, 2017|

Toronto, ON, Nov. 15, 2017 (GLOBE NEWSWIRE) -- ALGAE DYNAMICS CORP (OTC: ADYNF) (the "Company"), a developer of unique health products utilizing cannabis and algae oils, today announced that it has secured a US$250,000 investment from Teewinot Life Sciences Corporation (“Teewinot”). Teewinot is a leader in the development of biosynthetic cannabinoids that have the identical chemical structure of cannabinoids found in the Cannabis plant. The Company intends to use the funds for its research programs with The University of Waterloo and University of Western Ontario, that have been announced previously, as well as for general & administrative expenses and compliance. Paul Ramsay, the Company’s Chairman and President said, “These funds will allow us to continue [...]

16 08, 2017

ALGAE DYNAMICS CORP ENTERS INTO A LETTER OF INTENT WITH BONIFY TO PRODUCE UNIQUE CANNABIS OIL PRODUCT S ; ACCELERATES GO – TO – MARKET STRATEGY

2018-10-16T23:20:17+00:00August 16th, 2017|

TORONTO, ON--(Marketwired - Aug 16, 2017) - ALGAE DYNAMICS CORP (OTCQB: ADYNF) (the "Company"), a company focused on the development of unique health products and pharmaceuticals utilizing cannabis and algae oils, today announced that it has further refined its relationship with 6779264 Manitoba Ltd dba Bonify ("Bonify") in a Letter of Intent ("LOI") dated August 10, 2017. Bonify is a Licensed Producer, pursuant to the Access to Cannabis for Medical Purposes Regulations in Canada, with the capability to grow multiple strains of cannabis in its state-of-the-art 320,000 square foot facility. The Company previously announced a Memorandum of Understanding with Bonify on May 9, 2017, in which Bonify agreed to supply raw cannabis plant material for [...]

Load More Posts